Analysis of vancomycin therapeutic drug monitoring trends at pediatric hospitals

Pediatric Infectious Disease Journal

Volumn 32, Issue 1, 2013, Pages 32-35

  Moffett, Brady S ^a   Edwards, Morven S ^b  

^a TEXAS CHILDREN S HOSPITAL   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

therapeutic drug monitoring; vancomycin; vancomycin resistance

Indexed keywords

VANCOMYCIN;

ADOLESCENT; ADULT; ANTIBIOTIC THERAPY; CHILD; CLINICAL EVALUATION; DESCRIPTIVE RESEARCH; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG EFFICACY; DRUG MONITORING; DRUG SAFETY; DRUG USE; DRUG UTILIZATION; FEMALE; GROUPS BY AGE; HOSPITALIZATION; HUMAN; INFANT; INFECTION; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION SYSTEM; MEDICAL PRACTICE; MULTICENTER STUDY; NEWBORN; PEDIATRIC HOSPITAL; PRACTICE GUIDELINE; PRESCHOOL CHILD; PRIORITY JOURNAL; RETROSPECTIVE MEMORY; REVIEW; SCHOOL CHILD; TERTIARY HEALTH CARE; TREATMENT DURATION; TREND STUDY; UNITED STATES;

ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; CHILD; CHILD, PRESCHOOL; DRUG MONITORING; DRUG RESISTANCE, BACTERIAL; DRUG UTILIZATION; FEMALE; HOSPITALS, PEDIATRIC; HUMANS; INFANT; INFANT, NEWBORN; MALE; RETROSPECTIVE STUDIES; UNITED STATES; VANCOMYCIN;

EID: 84871748063     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e31826fd98d     Document Type: Review

References (27)

1. Rybak M, Lomaestro B, Rotschafer JC, et al. Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists. Am J Health Syst Pharm. 2009;66:82-98.
2. Thomson AH, Staatz CE, Tobin CM, et al. Development and evaluation of vancomycin dosage guidelines designed to achieve new target concentrations. J Antimicrob Chemother. 2009;63:1050-1057.
3. Lomaestro BM. Vancomycin dosing and monitoring 2 years after the guidelines. Expert Rev Anti Infect Ther. 2011;9:657-667.
4. Kullar R, Leonard SN, Davis SL, et al. Validation of the effectiveness of a vancomycin nomogram in achieving target trough concentrations of 15-20 mg/L suggested by the vancomycin consensus guidelines. Pharmacotherapy. 2011;31:441-448.
5. Rybak MJ, Lomaestro BM, Rotschafer JC, et al. Vancomycin therapeutic guidelines: a summary of consensus recommendations from the infectious diseases Society of America, the American Society of Health-System Pharmacists, and the Society of Infectious Diseases Pharmacists. Clin Infect Dis. 2009;49:325-327.
6. Frymoyer A, Hersh AL, Benet LZ, et al. Current recommended dosing of vancomycin for children with invasive methicillin-resistant Staphylococcus aureus infections is inadequate. Pediatr Infect Dis J. 2009;28: 398-402.
7. Frymoyer A, Hersh AL, Coralic Z, et al. Prediction of vancomycin pharmacodynamics in children with invasive methicillin-resistant Staphylococcus aureus infections: a Monte Carlo simulation. Clin Ther. 2010;32: 534-542.
8. Frymoyer A, Guglielmo BJ, Wilson SD, et al. Impact of a hospitalwide increase in empiric pediatric vancomycin dosing on initial trough concentrations. Pharmacotherapy. 2011;31:871-876.
9. Eiland LS, English TM, Eiland EH 3rd. Assessment of vancomycin dosing and subsequent serum concentrations in pediatric patients. Ann Pharmacother. 2011;45:582-589.
10. Piro CC, Crossno CL, Collier A, et al. Initial vancomycin dosing in pediatric oncology and stem cell transplant patients. J Pediatr Hematol Oncol. 2009;31:3-7.
11. Miles MV, Li L, Lakkis H, et al. Special considerations for monitoring vancomycin concentrations in pediatric patients. Ther Drug Monit. 1997;19:265-270. (Pubitemid 28053479)
12. Logsdon BA, Lee KR, Barrett FF. Correct dosing of vancomycin in infants and children. Pediatrics. 1995;96:1177.
13. Kim DI, Im MS, Choi JH, et al. Therapeutic monitoring of vancomycin according to initial dosing regimen in pediatric patients. Korean J Pediatr. 2010;53:1000-1005.
14. Kahyaoglu O, Akpinar M, Nolan B, et al. Vancomycin use and monitoring in pediatric patients in a community hospital. Infect Control Hosp Epidemiol. 1998;19:299-301.
15. Hing WC, Bek SJ, Lin RT, et al. A retrospective drug utilization evaluation of vancomycin usage in paediatric patients. J Clin Pharm Ther. 2004;29:359-365. (Pubitemid 39062166)
16. Hersh AL, Shapiro DJ, Newland JG, et al. Variability in pediatric infectious disease consultants' recommendations for management of community-acquired pneumonia. PLoS ONE. 2011;6:e20325.
17. Herigon JC, Hersh AL, Gerber JS, et al. Antibiotic management of Staphylococcus aureus infections in US children's hospitals, 1999-2008. Pediatrics. 2010;125:e1294-e1300.
18. Bafeltowska JJ, Buszman E, Mandat KM, et al. Therapeutic vancomycin monitoring in children with hydrocephalus during treatment of shunt infections. Surg Neurol. 2004;62:142-50; discussion 150. (Pubitemid 38917091)
19. Thomas MP, Steele RW. Monitoring serum vancomycin concentrations in children: is it necessary? Pediatr Infect Dis J. 1998;17:351-353. (Pubitemid 28208215)
20. Alós JI, García-Cañas A, García-Hierro P, et al. Vancomycin MICs did not creep in Staphylococcus aureus isolates from 2002 to 2006 in a setting with low vancomycin usage. J Antimicrob Chemother. 2008;62: 773-775.
21. Jimenez-Truque N, Thomsen I, Saye E, et al. Should higher vancomycin trough levels be targeted for invasive community-acquired methicillin-resistant Staphylococcus aureus infections in children? Pediatr Infect Dis J. 2010;29:368-370.
22. Zheng X, Qi C, Arrieta M, et al. Lack of increase in vancomycin resistance of pediatric methicillin-resistant Staphylococcus aureus isolates from 2000 to 2007. Pediatr Infect Dis J. 2010;29:882-884.
23. Liu C, Bayer A, Cosgrove SE et al. Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin- resistant Staphylococcus aureus infections in adults and children. Clin Infect Dis. 2011;52:1-38.
24. van Hal SJ, Lodise TP, Paterson DL. The clinical significance of vancomycin minimum inhibitory concentration in Staphylococcus aureus infections: a systematic review and meta-analysis. Clin Infect Dis. 2012;54: 755-771.
25. Deresinski S. Methicillin-resistant Staphylococcus aureus and vancomycin: minimum inhibitory concentration matters. Clin Infect Dis. 2012;54: 772-774.
26. Goodman DM, Hall M, Levin A, et al. Adults with chronic health conditions originating in childhood: inpatient experience in children's hospitals. Pediatrics. 2011;128:5-13.
27. Rossano JW, Smith EO, Fraser CD Jr, et al. Adults undergoing cardiac surgery at a children's hospital: an analysis of perioperative morbidity. Ann Thorac Surg. 2007;83:606-612. (Pubitemid 46135443)